WORLD NEWS – CANADA: A dramatic scientific breakthrough at the University of British Columbia produced an enzyme that converted a donor kidney’s blood type from A to the universal O and enabled that organ to be successfully transplanted into a human, marking a potential turning point in transplantation. The converted kidney became a universally compatible organ in a first-of-its-kind procedure that could reshape how surgeons match donors and recipients.
Developed over more than a decade on the UBC campus, the enzymatic technique works by removing antigenic surface sugars that trigger immune rejection. By stripping away that outer molecular layer, the method exposes an underlying O-type antigen that is tolerated by virtually any recipient. Clinicians describe the process as akin to removing paint to reveal primer: once the antigenic signal is gone, recipient antibodies no longer bind and launch the destructive immune cascade that causes graft failure.
The research, led by Dr. Steven Withers with the support of lab technicians and students, was published in Nature Biomedical Engineering and documents the first successful transplantation using an enzymatically converted kidney. Investigators emphasize that the same approach could be applied to blood and other tissues, potentially turning many donations into universal matches. With this proof of concept, the team is preparing to move into clinical trials to test safety, durability, and broader applicability.
The urgency is clear: roughly 3,500 Canadians and about 100,000 Americans are waiting for organ transplants, with about 75 percent of U.S. candidates seeking kidneys. Canadian Blood Services reports more than 200 Canadians die each year waiting. Physicians and researchers involved are acknowledged for their dedication, and proponents say enzymatic conversion could dramatically reduce waitlists, prevent deaths on transplant lists, and expand access to lifesaving organs worldwide. Regulators and hospitals will now weigh how fast to proceed.
